Related Experiment Video
Updated: Jan 5, 2026

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
Site-Specific Conjugation to Cys-Engineered THIOMAB™ Antibodies
Pragya Adhikari1, Neelie Zacharias1, Rachana Ohri1
1Department of Protein Chemistry, Genentech, Inc., South San Francisco, CA, USA.
Abstract:
Antibodies bearing engineered cysteine residues (termed THIOMAB™ antibodies) enable the site-selective attachment of a drug, label or other payload for specific delivery to certain tissues (e.g., tumors). This Chapter describes detailed methods we have developed and optimized for the conjugation, purification and analysis of THIOMAB™ antibody drug conjugates (TDCs).
More Related Videos
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
11:25Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Related Concept Videos
Mechanism of Conjugation
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...